Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

MYR Shares Post Record Results Despite Recent Pullback

Andreas Sommer by Andreas Sommer
September 2, 2025
in Analysis, Earnings, Value & Growth
0
MYR Stock
0
SHARES
203
VIEWS
Share on FacebookShare on Twitter

MYR Group Inc. (MYR) is demonstrating formidable financial strength, with its latest quarterly figures revealing substantial outperformance. A strategic emphasis on high-growth sectors is fueling this success, even as the stock experiences a near-term price correction.

Stellar Quarterly Outperformance

The company’s Q2 2025 earnings report delivered a significant positive surprise. Earnings per share (EPS) surged to $1.70, soundly beating the consensus analyst forecast of $1.56. Revenue climbed to $900.33 million, marking an 8.6% year-over-year increase and comfortably exceeding projections of $828.20 million.

Soaring Profitability and a Robust Backlog

This impressive top-line growth translated directly into enhanced profitability. The gross profit figure skyrocketed to $103.7 million for the second quarter of 2025, a dramatic rise from the $40.8 million recorded in the same period last year. Consequently, the gross margin expanded significantly to 11.5%, up from 4.9%, highlighting markedly improved operational efficiency and the successful execution of highly lucrative projects.

Supporting future revenue visibility, the company’s current backlog stands at a substantial $2.64 billion.

Key Q2 2025 Financial Metrics:
* EPS: $1.70 (surpassing estimates by $0.14)
* Revenue: $900.33 million (an 8.6% year-over-year increase)
* Net Income: Achieved a record $26.5 million
* EBITDA: Reached a record high of $55.6 million

Should investors sell immediately? Or is it worth buying MYR?

Strong Institutional Backing and Share Buybacks

Confidence in MYR is evident among major investors. Institutional entities have been aggressively increasing their stakes. Next Century Growth Investors LLC raised its holding by 1.9%, while the State of Wyoming amplified its position by a remarkable 544.5% in the first quarter. Collectively, institutional investors now control 88.90% of the company’s shares.

Further underscoring management’s belief in the company’s value, a new $75 million share repurchase program was announced in late July. With available liquidity of $383 million, MYR retains ample financial flexibility to continue pursuing its growth initiatives alongside the buyback.

Stock Momentum and Analyst Outlook

Although the share price declined by $4.26 to close at $187.27 on Monday, key technical indicators suggest the overarching upward trend remains intact. The stock continues to trade above its 50-day moving average of $186.64 and its 200-day moving average of $153.32.

MYR commands a market valuation of $2.91 billion, with a P/E ratio of 39.10. The analyst consensus continues to be favorable, maintaining a “Moderate Buy” rating. The average price target is $191.83, with recent bullish sentiment including KeyCorp raising its target from $205.00 to $211.00 and reaffirming its “Overweight” recommendation.

Capitalizing on the Data Center Expansion

A pivotal driver for MYR’s growth strategy is the exponentially expanding data center market. Industry forecasts suggest data centers could account for up to 9% of total U.S. electricity consumption by 2030. MYR is strategically positioned to benefit from this boom, particularly through its subsidiary, Sturgeon Electric, which was recently awarded a major $90 million data center construction project.

Ad

MYR Stock: Buy or Sell?! New MYR Analysis from February 7 delivers the answer:

The latest MYR figures speak for themselves: Urgent action needed for MYR investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

MYR: Buy or sell? Read more here...

Tags: MYR
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Repay Holdings Stock
Analysis

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Graftech Stock
Commodities

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026
Next Post
PennantPark Floating Rate Capital Stock

PennantPark Maintains Dividend Payout Despite Quarterly Earnings Shortfall

Clene Stock

A Pivotal Year for Clene's Neurological Treatment Pipeline

Alphabet Stock

Strategic Cloud Alliance with Meta Fuels Alphabet's AI Ambitions

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com